CoChat

On the safety of repeated ketamine infusions for the treatment of depression: Effects of sex and developmental periods

Open access
Strong, C.E., Kabbaj, Mohamed · 2018 · Neurobiology of Stress
Cited by 60

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

In this review, we will discuss the safety of repeated treatments with ketamine for patients with treatment-resistant depression (TRD), a condition in which patients with major depression do not show any clinical improvements following treatments with at least two antidepressant drugs. We will discuss the effects of these treatments in both sexes at different developmental periods. Numerous small clinical studies have shown that a single, low-dose ketamine infusion can rapidly alleviate depressive symptoms and thoughts of suicidality in patients with TRD, and these effects can last for about one week. Interestingly, the antidepressant effects of ketamine can be prolonged with intermittent, repeated infusion regimens and produce more robust therapeutic effects when compared to a single infusion. The safety of such repeated treatments with ketamine has not been thoroughly investigated. Although more studies are needed, some clinical and preclinical reports indicated that repeated infusions of low doses of ketamine may have addictive properties, and suggested that adolescent and adult female subjects may be more sensitive to ketamine's addictive effects. Additionally, during ketamine infusions, many TRD patients report hallucinations and feelings of dissociation and depersonalization, and therefore the effects of repeated treatments of ketamine on cognition must be further examined. Some clinical reports indicated that, compared to women, men are more sensitive to the psychomimetic effects of ketamine. Preclinical studies extended these findings to both adolescent and adult male rodents and showed that male rodents at both developmental periods are more sensitive to ketamine's cognitive-altering effects. Accordingly, in this review we shall focus our discussion on the potential addictive and cognitive-impairing effects of repeated ketamine infusions in both sexes at two important developmental periods: adolescence and adulthood. Although more work about the safety of ketamine is warranted, we hope this review will bring some answers about the safety of treating TRD with repeated ketamine infusions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ynstr.2018.09.001

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 99

  1. Adler, 1998, Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers, Biol. Psychiatr., 43, 811, 10.1016/S0006-3223(97)00556-8 · DOI · Paper page
  2. Andrews, 2002, Preventing major depression in young people, Br. J. Psychiatry, 181, 460, 10.1192/bjp.181.6.460 · DOI
  3. Bartoli, 2017, Ketamine as a rapid-acting agent for suicidal ideation: a meta-analysis, Neurosci. Biobehav. Rev., 77, 232, 10.1016/j.neubiorev.2017.03.010 · DOI
  4. Becker, 2003, Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 27, 687, 10.1016/S0278-5846(03)00080-0 · DOI · Paper page
  5. Berman, 2000, Antidepressant effects of ketamine in depressed patients, Biol. Psychiatr., 47, 351, 10.1016/S0006-3223(99)00230-9 · DOI · Paper page
  6. Bonnet, 2015, Long-term ketamine self-injections in major depressive disorder: focus on tolerance in ketamine's antidepressant response and the development of ketamine addiction, J. Psychoact. Drugs, 47, 276, 10.1080/02791072.2015.1072653 · DOI · Paper page
  7. Botanas, 2015, Methoxetamine, a ketamine derivative, produced conditioned place preference and was self-administered by rats: evidence of its abuse potential, Pharmacol. Biochem. Behav., 133, 31, 10.1016/j.pbb.2015.03.007 · DOI
  8. Caffino, 2016, The modulation of BDNF expression and signalling dissects the antidepressant from the reinforcing properties of ketamine: effects of single infusion vs. chronic self-administration in rats, Pharmacol. Res., 104, 22, 10.1016/j.phrs.2015.12.014 · DOI
  9. Caffino, 2017, Ketamine self-administration elevates alphaCaMKII autophosphorylation in mood and reward-related brain regions in rats, Mol. Neurobiol., 55, 5453, 10.1007/s12035-017-0772-3 · DOI
  10. Camarini, 2016, Behavioral sensitization to ethanol: neural basis and factors that influence its acquisition and expression, Brain Res. Bull., 125, 53, 10.1016/j.brainresbull.2016.04.006 · DOI · Paper page
  11. Celia Moreira Borella, 2016, Gender and estrous cycle influences on behavioral and neurochemical alterations in adult rats neonatally administered ketamine, Dev. Neurobiol., 76, 519, 10.1002/dneu.22329 · DOI
  12. Chang, 2016, Major depressive disorder induced by chronic ketamine abuse: a case report, Prim. Care Companion CNS Disord., 18
  13. Cho, 2005, Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine, Psychopharmacology (Berl), 179, 136, 10.1007/s00213-004-2066-5 · DOI
  14. Cohen, 2015, Assessing rodent hippocampal involvement in the novel object recognition task. A review, Behav. Brain Res., 285, 105, 10.1016/j.bbr.2014.08.002 · DOI · Paper page
  15. Costumero, 2017, Left frontoparietal network activity is modulated by drug stimuli in cocaine addiction, Brain Imag. Behav.
  16. Curran, 2001, In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users, Addiction, 96, 749, 10.1046/j.1360-0443.2001.96574910.x · DOI · Paper page
  17. Cusin, 2017, Ketamine augmentation for outpatients with treatment-resistant depression: preliminary evidence for two-step intravenous dose escalation, Aust. N. Z. J. Psychiatr., 51, 55, 10.1177/0004867416631828 · DOI · Paper page
  18. D'Souza, 2012, Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia, Biol. Psychiatr., 72, 785, 10.1016/j.biopsych.2012.05.009 · DOI
  19. De Luca, 2011, Ketamine self-administration in the rat: evidence for a critical role of setting, Psychopharmacology (Berl), 214, 549, 10.1007/s00213-010-2062-x · DOI · Paper page
  20. Diamond, 2014, Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic, J. Psychopharmacol., 28, 536, 10.1177/0269881114527361 · DOI · Paper page
  21. Dodman, 2015, Ceftriaxone reverses ketamine-induced lasting EEG and astrocyte alterations in juvenile mice, Drug Alcohol Depend., 156, 14, 10.1016/j.drugalcdep.2015.07.1198 · DOI
  22. Dossat, 2018, Behavioral and biochemical sensitivity to low doses of ketamine: influence of estrous cycle in C57BL/6 mice, Neuropharmacology, 130, 30, 10.1016/j.neuropharm.2017.11.022 · DOI · Paper page
  23. Doyle, 2013, Quantifying the attenuation of the ketamine pharmacological magnetic resonance imaging response in humans: a validation using antipsychotic and glutamatergic agents, J. Pharmacol. Exp. Therapeut., 345, 151, 10.1124/jpet.112.201665 · DOI
  24. Evans, 2012, The effects of NMDA subunit composition on calcium influx and spike timing-dependent plasticity in striatal medium spiny neurons, PLoS Comput. Biol., 8, 10.1371/journal.pcbi.1002493 · DOI
  25. Featherstone, 2012, Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice, Neurobiol. Dis., 47, 338, 10.1016/j.nbd.2012.05.003 · DOI · Paper page
  26. Franceschelli, 2015, Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naive and "depressed" mice exposed to chronic mild stress, Neuroscience, 290, 49, 10.1016/j.neuroscience.2015.01.008 · DOI · Paper page
  27. Fu, 2012, Effects of aging on mRNA profiles for drug-metabolizing enzymes and transporters in livers of male and female mice, Drug Metab. Dispos., 40, 1216, 10.1124/dmd.111.044461 · DOI
  28. Gazzaley, 1996, Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus, J. Neurosci., 16, 6830, 10.1523/JNEUROSCI.16-21-06830.1996 · DOI · Paper page
  29. Gierski, 2013, Executive functions in adult offspring of alcohol- dependent probands: toward a cognitive endophenotype?, Alcohol Clin. Exp. Res., 37, E356
  30. Hampson, 1990, Estrogen-related variations in human spatial and articulatory-motor skills, Psychoneuroendocrinology, 15, 97, 10.1016/0306-4530(90)90018-5 · DOI · Paper page
  31. Hauser, 2017, Disturbances of novel object exploration and recognition in a chronic ketamine mouse model of schizophrenia, Behav. Brain Res., 332, 316, 10.1016/j.bbr.2017.06.013 · DOI
  32. Jamadar, 2012, Memantine, an NMDA receptor antagonist, differentially influences Go/No-Go performance and fMRI activity in individuals with and without a family history of alcoholism, Psychopharmacology (Berl), 222, 129, 10.1007/s00213-011-2628-2 · DOI
  33. Kaminer, 2007, Comorbid adolescent substance use and major depressive disorders: a review, Psychiatry (Edgmont), 4, 32
  34. Keilhoff, 2004, Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia, Neuroscience, 126, 591, 10.1016/j.neuroscience.2004.03.039 · DOI · Paper page
  35. Kekesi, 2015, Sex-specific alterations in behavioral and cognitive functions in a "three hit" animal model of schizophrenia, Behav. Brain Res., 284, 85, 10.1016/j.bbr.2015.02.015 · DOI
  36. Kiraly, 2017, Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome, Transl. Psychiatry, 7, e1065, 10.1038/tp.2017.31 · DOI · Paper page
  37. Kos, 2011, The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice, Psychopharmacology (Berl), 214, 911, 10.1007/s00213-010-2102-6 · DOI · Paper page
  38. Lahti, 1995, Ketamine activates psychosis and alters limbic blood flow in schizophrenia, Neuroreport, 6, 869, 10.1097/00001756-199504190-00011 · DOI · Paper page
  39. Lahti, 2001, Effects of ketamine in normal and schizophrenic volunteers, Neuropsychopharmacology, 25, 455, 10.1016/S0893-133X(01)00243-3 · DOI · Paper page
  40. Laurie, 1997, Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies, Brain Res. Mol. Brain Res., 51, 23, 10.1016/S0169-328X(97)00206-4 · DOI · Paper page
  41. Li, 2008, Cannabinoid CB(1) receptor antagonist rimonabant attenuates reinstatement of ketamine conditioned place preference in rats, Eur. J. Pharmacol., 589, 122, 10.1016/j.ejphar.2008.04.051 · DOI
  42. Liang, 2013, Cognitive impairments in poly-drug ketamine users, Addict. Behav., 38, 2661, 10.1016/j.addbeh.2013.06.017 · DOI
  43. Liang, 2015, Ketamine users have high rates of psychosis and/or depression, J. Addict. Nurs., 26, 8, 10.1097/JAN.0000000000000060 · DOI
  44. Majewski-Tiedeken, 2008, Ketamine exposure in adult mice leads to increased cell death in C3H, DBA2 and FVB inbred mouse strains, Drug Alcohol Depend., 92, 217, 10.1016/j.drugalcdep.2007.08.009 · DOI
  45. Malhotra, 1996, NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers, Neuropsychopharmacology, 14, 301, 10.1016/0893-133X(95)00137-3 · DOI · Paper page
  46. McDougall, 2017, Effects of ketamine on the unconditioned and conditioned locomotor activity of preadolescent and adolescent rats: impact of age, sex, and drug dose, Psychopharmacology (Berl), 234, 2683, 10.1007/s00213-017-4660-3 · DOI
  47. McGowan, 2017, Prophylactic ketamine attenuates learned fear, Neuropsychopharmacology, 42, 1577, 10.1038/npp.2017.19 · DOI
  48. Monyer, 1994, Developmental and regional expression in the rat brain and functional properties of four NMDA receptors, Neuron, 12, 529, 10.1016/0896-6273(94)90210-0 · DOI · Paper page
  49. Morgan, 2006, Greater vulnerability to the amnestic effects of ketamine in males, Psychopharmacology (Berl), 187, 405, 10.1007/s00213-006-0409-0 · DOI · Paper page
  50. Muthukumaraswamy, 2015, Evidence that subanesthetic doses of ketamine cause sustained disruptions of NMDA and AMPA-mediated frontoparietal connectivity in humans, J. Neurosci., 35, 11694, 10.1523/JNEUROSCI.0903-15.2015 · DOI · Paper page
  51. Nagy, 2015, Delayed emergence of behavioral and electrophysiological effects following juvenile ketamine exposure in mice, Transl. Psychiatry, 5, e635, 10.1038/tp.2015.111 · DOI
  52. Narendran, 2005, Altered prefrontal dopaminergic function in chronic recreational ketamine users, Am. J. Psychiatr., 162, 2352, 10.1176/appi.ajp.162.12.2352 · DOI · Paper page
  53. Neill, 2010, Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism, Pharmacol. Ther., 128, 419, 10.1016/j.pharmthera.2010.07.004 · DOI · Paper page
  54. Newcomer, 1999, Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis, Neuropsychopharmacology, 20, 106, 10.1016/S0893-133X(98)00067-0 · DOI · Paper page
  55. Ng, 2017, Depression and substance use comorbidity: what we have learned from animal studies, Am. J. Drug Alcohol Abuse, 43, 456, 10.1080/00952990.2016.1183020 · DOI
  56. Nikiforuk, 2014, The effects of acute and repeated administration of ketamine on attentional performance in the five-choice serial reaction time task in rats, Eur. Neuropsychopharmacol, 24, 1381, 10.1016/j.euroneuro.2014.04.007 · DOI
  57. Nugent, 2014, Neural correlates of rapid antidepressant response to ketamine in bipolar disorder, Bipolar Disord., 16, 119, 10.1111/bdi.12118 · DOI · Paper page
  58. Ontl, 2004, Development and aging of N-methyl-D-aspartate receptor expression in the prefrontal/frontal cortex of mice, Neuroscience, 123, 467, 10.1016/j.neuroscience.2003.09.006 · DOI
  59. Papakostas, 2003, Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder, J. Clin. Psychiatr., 64, 1357, 10.4088/JCP.v64n1112 · DOI · Paper page
  60. Pare, 1993, Sex differences and stress response of WKY rats, Physiol. Behav., 54, 1179, 10.1016/0031-9384(93)90345-G · DOI · Paper page
  61. Parise, 2013, Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats, Biol. Psychiatr., 74, 750, 10.1016/j.biopsych.2013.04.027 · DOI · Paper page
  62. Paul, 2010, NR2B-NMDA receptor-mediated increases in intracellular Ca2+ concentration regulate the tyrosine phosphatase, STEP, and ERK MAP kinase signaling, J. Neurochem., 114, 1107, 10.1111/j.1471-4159.2010.06835.x · DOI
  63. Petrakis, 2004, Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism, Am. J. Psychiatr., 161, 1776, 10.1176/ajp.161.10.1776 · DOI · Paper page
  64. Phelps, 2009, Family history of alcohol dependence and initial antidepressant response to an N- methyl-D-aspartate antagonist, Biol. Psychiatr., 65, 181, 10.1016/j.biopsych.2008.09.029 · DOI · Paper page
  65. Roca, 2015, Cognitive impairments and depression: a critical review, Actas Esp. Psiquiatr., 43, 187
  66. Rocha, 2017, Differences between adolescents and adults in the acute effects of PCP and ketamine and in sensitization following intermittent administration, Pharmacol. Biochem. Behav., 157, 24, 10.1016/j.pbb.2017.04.007 · DOI
  67. Rustay, 2001, Sensitivity and tolerance to ethanol-induced incoordination and hypothermia in HAFT and LAFT mice, Pharmacol. Biochem. Behav., 70, 167, 10.1016/S0091-3057(01)00595-0 · DOI
  68. Saland, 2017, Integrative analysis of sex differences in the rapid antidepressant effects of ketamine in preclinical models for individualized clinical outcomes, Curr. Opin. Behav. Sci., 14, 19, 10.1016/j.cobeha.2016.11.002 · DOI
  69. Sans, 2000, Postnatal developmental changes in AMPA and NMDA receptors in the rat vestibular nuclei, Brain Res. Dev. Brain Res., 123, 41, 10.1016/S0165-3806(00)00082-1 · DOI
  70. Santamaria, 2014, In vitro ketamine CYP3A-mediated metabolism study using mammalian liver S9 fractions, cDNA expressed enzymes and liquid chromatography tandem mass spectrometry, Biomed. Chromatogr., 28, 1660, 10.1002/bmc.3199 · DOI
  71. Schak, 2016, Potential risks of poorly monitored ketamine use in depression treatment, Am. J. Psychiatr., 173, 215, 10.1176/appi.ajp.2015.15081082 · DOI
  72. Schoepfer, 2017, Sex- and dose-dependent abuse liability of repeated subanesthetic ketamine in rats, Physiol. Behav.
  73. Seshadri, 2018, Altered avalanche dynamics in a developmental NMDAR hypofunction model of cognitive impairment, Transl. Psychiatry, 8, 3, 10.1038/s41398-017-0060-z · DOI
  74. Shen, 2011, Heroin relapse requires long-term potentiation-like plasticity mediated by NMDA2b-containing receptors, Proc. Natl. Acad. Sci. U. S. A., 108, 19407, 10.1073/pnas.1112052108 · DOI · Paper page
  75. Shiroma, 2014, Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression, J. Affect. Disord., 155, 123, 10.1016/j.jad.2013.10.036 · DOI · Paper page
  76. Silvestre de Ferron, 2015, Two binges of ethanol a day keep the memory away in adolescent rats: key role for GLUN2B subunit, Int. J. Neuropsychopharmacol., 19, 10.1093/ijnp/pyv087 · DOI
  77. Sos, 2013, Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression, Neuroendocrinol. Lett., 34, 287
  78. Spear, 2000, The adolescent brain and age-related behavioral manifestations, Neurosci. Biobehav. Rev., 24, 417, 10.1016/S0149-7634(00)00014-2 · DOI · Paper page
  79. Stefanovic, 2009, Acute and chronic effects of ketamine on semantic priming: modeling schizophrenia?, J. Clin. Psychopharmacol., 29, 124, 10.1097/JCP.0b013e31819a4b91 · DOI
  80. Strong, 2017, Locomotor sensitization to intermittent ketamine administration is associated with nucleus accumbens plasticity in male and female rats, Neuropharmacology, 121, 195, 10.1016/j.neuropharm.2017.05.003 · DOI
  81. Sundermann, 2016, Female advantage in verbal memory: evidence of sex-specific cognitive reserve, Neurology, 87, 1916, 10.1212/WNL.0000000000003288 · DOI · Paper page
  82. Suzuki, 2000, Effects of the non-competitive NMDA receptor antagonist ketamine on morphine-induced place preference in mice, Life Sci., 67, 383, 10.1016/S0024-3205(00)00639-1 · DOI
  83. Tang, 2015, Chronic administration of ketamine mimics the perturbed sense of body ownership associated with schizophrenia, Psychopharmacology (Berl), 232, 1515, 10.1007/s00213-014-3782-0 · DOI
  84. Thelen, 2016, Repeated ketamine treatment induces sex-specific behavioral and neurochemical effects in mice, Behav. Brain Res., 312, 305, 10.1016/j.bbr.2016.06.041 · DOI
  85. Tizabi, 2012, Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar-Kyoto rats, Neuroscience, 213, 72, 10.1016/j.neuroscience.2012.03.052 · DOI · Paper page
  86. Tsujimoto, 2008, The prefrontal cortex: functional neural development during early childhood, Neuroscientist, 14, 345, 10.1177/1073858408316002 · DOI · Paper page
  87. Tuscher, 2016, Inhibition of local estrogen synthesis in the hippocampus impairs hippocampal memory consolidation in ovariectomized female mice, Horm. Behav., 83, 60, 10.1016/j.yhbeh.2016.05.001 · DOI · Paper page
  88. Van den Buuse, 2001, Estrogen increases prepulse inhibition of acoustic startle in rats, Eur. J. Pharmacol., 425, 33, 10.1016/S0014-2999(01)01139-6 · DOI
  89. van den Buuse, 2015, Chronic estrogen and progesterone treatment inhibits ketamine-induced disruption of prepulse inhibition in rats, Neurosci. Lett., 607, 72, 10.1016/j.neulet.2015.09.019 · DOI
  90. van der Kam, 2007, Effect of 2-methyl-6- (phenylethynyl) pyridine on intravenous self-administration of ketamine and heroin in the rat, Behav. Pharmacol., 18, 717, 10.1097/FBP.0b013e3282f18d58 · DOI
  91. Venniro, 2015, Pharmacological and non-pharmacological factors that regulate the acquisition of ketamine self-administration in rats, Psychopharmacology (Berl), 232, 4505, 10.1007/s00213-015-4077-9 · DOI
  92. Vetter-O'Hagen, 2012, Hormonal and physical markers of puberty and their relationship to adolescent-typical novelty-directed behavior, Dev. Psychobiol., 54, 523, 10.1002/dev.20610 · DOI · Paper page
  93. World Health Organization (WHO), 2012, Ketamine: expert peer review on critical review report. WHO: hammamet, Tunisia, June 4-8
  94. Wiley, 2008, Age-dependent differences in sensitivity and sensitization to cannabinoids and 'club drugs' in male adolescent and adult rats, Addict. Biol., 13, 277, 10.1111/j.1369-1600.2007.00077.x · DOI
  95. Wiley, 2011, Locomotor activity changes in female adolescent and adult rats during repeated treatment with a cannabinoid or club drug, Pharmacol. Rep., 63, 1085, 10.1016/S1734-1140(11)70627-2 · DOI
  96. Wise, 2014, The development and maintenance of drug addiction, Neuropsychopharmacology, 39, 254, 10.1038/npp.2013.261 · DOI · Paper page
  97. Wright, 2017, Reinforcing properties of an intermittent, low dose of ketamine in rats: effects of sex and cycle, Psychopharmacology (Berl), 234, 393, 10.1007/s00213-016-4470-z · DOI
  98. Zheng, 2017, Function of 38 variants CYP2C9 polymorphism on ketamine metabolism in vitro, J. Pharmacol. Sci., 135, 8, 10.1016/j.jphs.2017.08.006 · DOI
  99. Zhou, 2011, Substance-specific and shared transcription and epigenetic changes in the human hippocampus chronically exposed to cocaine and alcohol, Proc. Natl. Acad. Sci. U. S. A., 108, 6626, 10.1073/pnas.1018514108 · DOI · Paper page

Cited by

See all 60

Metadata

Authors
Strong, C. E., & Kabbaj, M.
Venue
Neurobiology of Stress
Publisher
Elsevier BV
Published
2018-11
Volume
9
Pages
166-175
ISSN
2352-2895 (ISSN-L)
OpenAlex
W2891058443
Cited by
60
References
31
FWCI
4.33
Type
journal article
Language
en
Open access
gold
Licence
Funders
National Institute of Mental Health (MH190450, R01 MH099085)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.